Veracyte is a global diagnostics company that empowers clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our growing menu of diagnostic tests answers important clinical questions to help patients avoid risky, costly procedures and interventions, and accelerate time to appropriate treatment.
View Top Employees from Veracyte, Inc.Website | http://www.veracyte.com |
Ticker | VCYT |
Revenue | $120 million |
Funding | $640.9 million |
Employees | 584 (584 on RocketReach) |
Founded | 2008 |
Address | 6000 Shoreline Court Suite 300, South San Francisco, California 94080, US |
Phone | (650) 243-6300 |
Fax | (650) 243-6301 |
Technologies |
JavaScript,
HTML,
PHP
+60 more
(view full list)
|
Industry | Biotechnology Research, Medical Testing & Clinical Laboratories, Biotechnology, AFIRMA® Thyroid FNA Analysis, Healthcare, Science and Engineering, Percepta® Bronchial Genomic Classifier, Health Care, ENVISIA™ Genomic Classifier, Health Diagnostics |
Web Rank | 2 Million |
Keywords | Cancer Diagnosis, Molecular Oncology, Oncology, Next Generation Sequencing, Personalized Cancer Care |
Competitors | Agendia, Biocartis, CareDx, Inc., Roka Bio, mdxhealth |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies |
Looking for a particular Veracyte, Inc. employee's phone or email?
The Veracyte, Inc. annual revenue was $120 million in 2024.
Marc Stapley is the CEO of Veracyte, Inc..
584 people are employed at Veracyte, Inc..
Veracyte, Inc. is based in South San Francisco, California.
The NAICS codes for Veracyte, Inc. are [541, 54171, 541714, 5417, 54].
The SIC codes for Veracyte, Inc. are [873, 87].